Related Experiment Videos
Adherence to HAART regimens
1Center for AIDS Prevention Studies, AIDS Research Institute, University of California, San Francisco, San Francisco, California, USA. mchesney@psg.ucsf.edu
AIDS Patient Care and Stds
|May 10, 2003
Summary
Improving adherence to highly active antiretroviral therapy (HAART) is crucial for managing HIV/AIDS. Patient-provider collaboration can enhance treatment effectiveness and long-term outcomes by tailoring regimens to patient lifestyles.
Area of Science:
- Infectious Diseases
- Pharmacology
- Public Health
Background:
- Inadequate adherence to highly active antiretroviral therapy (HAART) is a significant challenge in managing HIV/AIDS.
- Nonadherence can lead to drug-resistant HIV variants, treatment failure, and limited future therapeutic options.
Purpose of the Study:
- To review current understanding of adherence reporting in HIV treatment.
- To explore strategies for improving adherence to HAART.
- To enhance treatment outcomes for HIV infection and AIDS.
Main Methods:
- Literature review focusing on adherence to highly active antiretroviral therapy (HAART).
- Analysis of barriers to adherence, including regimen complexity, side effects, lifestyle factors, and patient-provider relationships.
- Examination of successful strategies for improving adherence.
Main Results:
- Barriers to HAART adherence mirror those in other chronic disease management.
- Patient-provider collaboration in selecting lifestyle-tailored regimens improves adherence.
- Key factors for enhanced adherence include convenient dosing, low pill burden, and tolerable side effects.
Conclusions:
- Successful long-term HIV/AIDS management requires at least 95% adherence to HAART.
- Collaborative, patient-centered approaches are essential for optimizing HAART adherence and treatment outcomes.
- Improving adherence transforms HIV infection into a manageable chronic illness.